IMPLANT FOR A BONE JOINT
20170224499 · 2017-08-10
Assignee
Inventors
- Gerry Clarke (County Galway, IE)
- Brendan Boland (County Kildare, IE)
- Mark Bruzzi (Galway, IE)
- Amy L. Ladd (Stanford, CA, US)
- Arnold-Peter C. Weiss (Barrington, RI, US)
Cpc classification
A61F2310/00029
HUMAN NECESSITIES
A61F2310/00023
HUMAN NECESSITIES
A61F2002/30331
HUMAN NECESSITIES
A61F2310/00017
HUMAN NECESSITIES
A61F2002/30065
HUMAN NECESSITIES
International classification
Abstract
An implant (30) for a mammalian bone joint (3) for spacing a first bone (2) of the joint from a second bone (1) of the joint while allowing translational movement of the second bone in relation to the first bone is described. The implant comprises (a) a distal part (31) configured for intramedullary engagement with an end of the second bone, (b) a proximal part (34) having a platform (15) configured for non-engaging abutment of an end of the first bone and translational movement thereon, and (c) an articulating coupling (10, 16) provided between the distal and proximal ends allowing controlled articulation of the first and second bones. The bone-abutting platform is shaped to conform to and translate upon the end of the first bone. A kit for assembly to form the implant of the invention, and the use of the implant to treat osteoarthritis in a bone joint, are also described.
Claims
1. An implant for a mammalian first carpometacarpal joint for spacing a trapezium bone of the joint from a first metacarpal bone of the joint while allowing translational movement of the first metacarpal bone in relation to the trapezium bone, the implant comprising (a) a distal part configured for intramedullary engagement with an end of the first metacarpal bone, (b) a proximal part having a curved saddle-shaped platform configured for non-engaging abutment of an end of the trapezium bone and translational movement thereon, and (c) an articulating coupling provided between the distal and proximal parts allowing controlled articulation of the trapezium and first metacarpal bones.
2. An implant according to claim 1 in which the articulating coupling is a ball and socket joint.
3. An implant according to claim 1 in which the socket is contained within the intermedullary distal part.
4. An implant according to claim 2 in which the socket is offset towards a volar side of the intermedullary distal part.
5. An implant according to claim 1 in which the distal part comprises an intramedullary stem configured for interference fit in a medullary cavity.
6. An implant according to claim 2 in which the articulating surface of the socket comprises a wear-resistant liner.
7. An implant according to claim 1 in which the distal part and/or proximal part is configured for length adjustment to vary the spacing between the trapezium and the first metacarpal.
8. An implant according to claim 7 in which the proximal or distal part comprises a bone abutting/engaging part, a coupling part and an adjustable spacer between the bone abutting/engaging part and the coupling part.
9. An implant according to claim 8 in which the adjustable spacer comprises a stem that threadingly engages the bone abutting/engaging part and is axially adjustable between an extended and retracted position, in which the stem is optionally configured to extend axially away from the bone generally parallel to a longitudinal axis of the second bone or at an angle to the longitudinal axis of the second bone.
10. An implant according to claim 1 in which the implant is a modular implant comprising a first component including the distal part and second component comprising the proximal part, in which the first or second component comprises the articulating coupling or the first component comprises part of the articulating coupling and the second component comprises another part of the articulating coupling.
11. A modular implant according to claim 10 and comprising three components: a first component comprising the proximal part having a first bone-abutting platform at one end and one of a ball or socket at an opposite end; a second component comprising the distal part having one end configured for intramedullary engagement with the second bone; and a third spacer component having one of a ball and socket at one and an opposite end configured for engagement with the second component.
12. An implant for a mammalian bone joint for spacing a first bone of the joint from a second bone of the joint while allowing translational movement of the second bone in relation to the first bone, the implant comprising (a) a first part configured for intramedullary engagement with an end of the second bone, (b) a second part having a platform configured for non-engaging abutment of an end of the first bone and translational movement thereon, and (c) an articulating coupling provided between the first and second parts allowing controlled articulation of the first and second bones, and in which the bone-abutting platform is shaped to conform to a natural shape of the end of the first bone.
13. An implant according to claim 12 in which the articulating coupling is a ball and socket joint.
14. An implant according to claim 13 in which the socket is contained within the first part.
15. An implant according to claim 13 in which the socket is offset from the longitudinal axis of the intermedullary first part.
16. An implant according to claim 12 in which the first part comprises an intramedullary stem configured for interference fit in a medullary cavity.
17. An implant according to claim 12 in which the bone joint is selected from a saddle joint, a metatarsophalangeal joint, and a glenohumeral joint.
18. An implant according to claim 17 and in which the bone joint is a metatarsophalangeal joint, in which the first part is configured for intermedullary engagement with the first metatarsal and the second part comprises a platform configured for non-engaging abutment of a proximal end of the plalanx.
19. An implant according to claim 17 and in which the bone joint is a first carpometacarpal joint and in which the mammal has had a trapeziectomy, in which the first part is configured for intermedullary engagement with the first metatcarpal and the second part is elongated and comprises a platform configured for non-engaging abutment of a proximal end of the scaphoid bone.
20. An implant according to claim 12 in which the articulating surfaces of the ball and/or socket comprise a wear-resistant liner, and/or in which the distal part and/or proximal part is configured for length adjustment to vary the spacing between the first and second bones.
Description
BRIEF DESCRIPTION OF THE FIGURES
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
DETAILED DESCRIPTION OF THE INVENTION
[0087] All publications, patents, patent applications and other references mentioned herein are hereby incorporated by reference in their entireties for all purposes as if each individual publication, patent or patent application were specifically and individually indicated to be incorporated by reference and the content thereof recited in full.
Definitions and General Preferences
[0088] Where used herein and unless specifically indicated otherwise, the following terms are intended to have the following meanings in addition to any broader (or narrower) meanings the terms might enjoy in the art;
[0089] Unless otherwise required by context, the use herein of the singular is to be read to include the plural and vice versa. The term “a” or “an” used in relation to an entity is to be read to refer to one or more of that entity. As such, the terms “a” (or “an”), “one or more,” and “at least one” are used interchangeably herein.
[0090] As used herein, the term “comprise,” or variations thereof such as “comprises” or “comprising,” are to be read to indicate the inclusion of any recited integer (e.g. a feature, element, characteristic, property, method/process step or limitation) or group of integers (e.g. features, element, characteristics, properties, method/process steps or limitations) but not the exclusion of any other integer or group of integers. Thus, as used herein the term “comprising” is inclusive or open-ended and does not exclude additional, unrecited integers or method/process steps.
[0091] As used herein, the term “disease” is used to define any abnormal condition that impairs physiological function and is associated with specific symptoms. The term is used broadly to encompass any disorder, illness, abnormality, pathology, sickness, condition or syndrome in which physiological function is impaired irrespective of the nature of the aetiology (or indeed whether the aetiological basis for the disease is established). It therefore encompasses conditions arising from infection, trauma, injury, surgery, radiological ablation, poisoning or nutritional deficiencies.
[0092] As used herein, the term “treatment” or “treating” refers to an intervention (e.g. the administration of an agent to a subject) which cures, ameliorates or lessens the symptoms of a disease or removes (or lessens the impact of) its cause(s) (for example, the reduction in accumulation of pathological levels of lysosomal enzymes). In this case, the term is used synonymously with the term “therapy”.
[0093] Additionally, the terms “treatment” or “treating” refers to an intervention (e.g. the administration of an agent to a subject) which prevents or delays the onset or progression of a disease or reduces (or eradicates) its incidence within a treated population. In this case, the term treatment is used synonymously with the term “prophylaxis”.
[0094] In the context of treatment and effective amounts as defined above, the term subject (which is to be read to include “individual”, “animal”, “patient” or “mammal” where context permits) defines any subject, particularly a mammalian subject, for whom treatment is indicated. Mammalian subjects include, but are not limited to, humans, domestic animals, farm animals, zoo animals, sport animals, pet animals such as dogs, cats, guinea pigs, rabbits, rats, mice, horses, cattle, cows: primates such as apes, monkeys, orangutans, and chimpanzees; canids such as dogs and wolves; felids such as cats, lions, and tigers; equids such as horses, donkeys, and zebras; food animals such as cows, pigs, and sheep: ungulates such as deer and giraffes: and rodents such as mice, rats, hamsters and guinea pigs. In preferred embodiments, the subject is a human.
[0095] “Implant” means a prosthetic implant suitable for implantation in the body and made from a material or materials that are biocompatible (i.e. will not elicit an immune response in the host). Examples of suitable materials include Titanium, UHMWHDPE, Cobalt-Chrome alloy (CoCr), 316 grade Stainless Steel, Zirconium, Carbon-fiber-reinforced polyetheretherketone (CFR-PEEK), and Pyrocarbon. The implant comprises a distal part (also referred to as an “intermedullary part” or a “first part”) and a proximal part (also referred to as a “bone-abutting part” or a “second part”). It should be noted that the distal part may be disposed on a proximal side of the joint (for example in the case of metatarsophalangeal joint illustrated in
[0096] “Mammalian bone joint” means one or more of the following: saddle joint (i.e thumb carpometacarpal joint), ball and socket joint (i.e. head of humerus and scapula joint or elbow humeroradial joint), hinge joint (i.e. interphalangeal joint in hand or foot, humeroulnar joint in elbow), pivot joint (i.e. radium ulna joint, intervertebral joint in spine, distal radioulnar joint in wrist), gliding joint (i.e. carpal bone in hand, acromioclavicular joint in shoulder, tarsometatarsal joint in foot), and condyloid joint (i.e. metacarpophalangeal joint in fingers, metatarsophalangeal joint in foot). In a preferred embodiment, the implant is configured for spacing articulating bones in a saddle joint. In a preferred embodiment, the implant is configured for spacing articulating bones in a carpometacarpal joint in the thumb. In one embodiment, the implant is configured for use with an arthritic bone joint. In one embodiment, the bone joint is one in which normal bone articulation includes translational movement of one bone in relation to the other bone. In one embodiment, the joint is an unnatural joint, for example a joint where one of the articulating bones has been removed, for example a first carpometacarpal joint in a subject that has undergone a trapeziectomy where the implant is placed between a first metcarpal and a scaphoid bone.
[0097] “Intramedullary engagement” means engagement within a medullary cavity formed or existing in the bone, where the cavity is generally but not exclusively formed along a longitudinal axis of the bone. In one embodiment, the intramedullary engagement fixture comprises a screw or nail or interference-fit stem, although other intramedullary fixtures are known. Typically, the screw is externally threaded. Intramedullary fixtures are sold by Smith & Nephew, Zimmer, Synthes and other suppliers. The engagement anchors the implant to the bone. In one embodiment, the medullary cavity is formed in a position that is offset towards a volar direction.
[0098] “Non-engaging abutment” means that the proximal part is not fixed to the first bone, but is configured to abut the end of the bone in a manner that allows translational movement thereof. How this is achieved depends on the joint being treated and the specific anatomy of the first bone. As an example, the when the joint is a carpometacarpal joint in the thumb, the end of the trapezium bone has a twisted saddle shape (see FIG. 2 of Turker et al, Indian J Plast Surg. 2011, 44(2): 308-316) and the platform is configured to rest upon this saddle and allow translational movement of the platform across the saddle. Thus, in this embodiment, the curved saddle-shaped platform typically has a concave-convex shape, which is explained below with reference to
[0099] “Translational movement of the second bone in relation to the first bone” means non-pivoting movement of the second bone in relation to the first bone. This can also be described as sliding movement. An example is the involuntary translational movement of the metacarpal in relation to the trapezium in the thumb carpometacarpal joint, which contributes significantly to extension-flexion articulation of the thumb. The implant of the invention facilitates such translational movement by employing a proximal part that is configured to non-engagingly abut the first bone.
[0100] “Articulating coupling” means a coupling that allows articulation between the first and second parts of the implant. The specific type of coupling employed in the implant depends on the joint that is being treated with the implant, and in some cases the indication or severity of the indication. For example, when the implant is for treatment of an arthritic hinge joint, for example an elbow joint, the implant will generally comprise a hinge joint coupling. When the implant is for treatment of a saddle joint, for example a carpometacarpal joint, the implant will generally comprise a ball and socket joint or a universal joint. “Controlled articulation” means that the articulation is constrained to specific types of articulation.
[0101] “Abutting platform” means a base that abuts the end of the first bone (for example the end of the trapezium) so that translational (i.e. sliding) movement of the platform in relation to the end of the bone is allowed. The bone is not fixed to the platform. The platform may be configured to conform to a surface of the top of the bone. In one embodiment, the platform is shaped to mimic an end of the second bone, so as to allow the same range of movements as the natural healthy joint, including translational movement. In the case of the carpometacarpal joint, where the end of the first bone (trapezium) has a twisted saddle topography, the platform may be shaped to conform to the twisted saddle to allow one or more or all of the following range of movements of the first metacarpal in relation to the trapezium: flexion, extension, abduction, adduction, internal rotation, external rotation, opposition, circumduction and translation.
[0102] “Modular implant” means that the implant is formed in at least two parts, for example three parts or four parts, and one or more of the parts may be replaced with a substitute part. For example, an implant may employ a proximal part that has a shape specific to a particular type of bone, or a different proximal part that has a shape specific to a different type of bone. Or an implant may have a distal part that comprises a screw for intramedullary engagement of the second bone, or a different distal part that comprises a nail for intramedullary engagement. The provision of a modular implant design allows a user to mix and match the different components to provide an implant that is tailored for a specific clinical situation.
[0103] “Osteoarthritis” is a condition that occurs when the protective cartilage on the ends of bones wears down or degenerates causing bone rubbing on bone. It most commonly occurs in joints of the hands, knees, hips and spine. Common symptoms include pain, tenderness and stiffness in the joints. Other forms of joint degeneration for which this device may be used in therapy for example to provide pain relief or structural integrity include post-traumatic arthritis, rheumatoid arthritis, psoriatic arthritis, and other forms of sero-negative and sero-positive arthropathies.
[0104] “Hemi-arthroplasty implant” means an implant that is configured for use in joint replacement where only one side of the joint is replaced or modified. The implants of the invention are predominantly hemi-arthroplasty implants, as the first bone is generally modified to receive the intermedullary anchor (and optionally by resection), the second bone is generally not modified, as the platform is configured to abut and translate upon the natural shape of the second bone.
EXEMPLIFICATION
[0105] The invention will now be described with reference to specific Examples. These are merely exemplary and for illustrative purposes only: they are not intended to be limiting in any way to the scope of the monopoly claimed or to the invention described. These examples constitute the best mode currently contemplated for practicing the invention.
[0106] Referring to the drawings, and initially to
[0107] Referring to
[0108]
[0109] Referring to
[0110] Although all of the figures and specific embodiments relate to an implant configured for use with a carpometacarpal joint, it will be appreciated that the implant of the invention can be easily adapted for use with other types of saddle joint and other types of non-saddle joints, such as hinge joints, ball-and-socket joint, and sliding joints, for example. It addition, it will be appreciated that while the specific embodiment describes an implant having a ball and socket coupling, other types of couplings may be employed such as for example a universal joint or a hinge joint.
[0111] Referring to
[0112]
[0113]
[0114] Referring to
[0115] Referring to
[0116] Referring to
[0117] Referring to
[0118]
[0119] Referring to
[0120] In one embodiment, the implant consists of two principal components, one male and one female. One component is typically fixed in the first metacarpal of the thumb—the metacarpal component and the second component is typically in contact with, and can translate upon, the trapezium—the trapezial component. Both principal components are generally connected to each other by means of a constrained ball and socket arrangement, and the female socket may be located on either the metacarpal or the trapezial side of the assembly.
[0121] The two principal components may be expanded to four (1), whereby the female socket component is fitted with a wear resistant liner, and a neck component comprising the ball is fitted into a housing to complete the male element of the design. The neck component may instead house the socket while the ball is integral with the translating trapezial component. The device may be presented in a range of sizes to suit a range of patient anatomy: this may be accomplished through providing a range of sizes for both metacarpal and trapezial components and a range of neck lengths. Similarly, necks may be straight or offset to compensate for individual anatomical variances, and sockets may also be offset (
[0122] Three specific embodiments are described below:
[0123] a. “Closed Procedure”: An interosseous approach whereby the metacarpal component and the trapezial component are connected together before insertion. The socket feature may be located on either component. The components may be manufactured from commonly used orthopaedic materials provided that metal on metal contact is avoided and the trapezial component is made from a material that is compatible with articulation directly on bone. For example, the metacarpal component may be made from Titanium and the trapezial component may be made from UHMWHDPE.
[0124] A guide or guide wire such as a Kirschner wire may be inserted into the metacarpal on the lateral border extending proximally to exit at the centre of the articular surface. A series of pre-drilling then prepares an opportunity to either tap threads for, or insert a self-tapping version of, the metacarpal component. The threads may be of buttress design, have a slow helix and may be truncated to aid osteo-integration. Similarly, the metacarpal component may be fenestrated and/or coated with a material such as hydroxlyapatite to aid osteo-integration. As it is pre-attached, the trapezial component, which is just smaller than the root diameter of the metacarpal threads, precedes the metacarpal component down the channel until it rests upon the surface of the trapezium. The undersurface of the trapezial component may be flat, of generic saddle shape, or may be configured to mate with the superior surface of the trapezium and may or may not be patient specific in this regard. This patient specificity may be accomplished by using visual imaging techniques in conjunction with additive manufacturing, CNC fabrication or other computer aided manufacturing techniques. The trapezial component is not attached to the trapezium but is designed for translation upon the superior surface of the trapezium. Once in contact with the trapezium and (if not flat) oriented to the correct position relative to the saddle of the trapezium aided by external imaging, the assembly may be advanced by manipulation of the proximal end of the metacarpal component to provide the chosen degree of joint distraction.
[0125] In this embodiment, a drill guide may be used to aid initial position of the K-wire and a succession of pre-drills may be made with cannulated drill bits before the metacarpal components is inserted.
[0126] b. “Open Procedure”: The metacarpal component may consist of a press-fit tapered stem inserted as an interference fit from the articular surface extending distally once the joint capsule has been exposed. Equally, the metacarpal component may be threaded into the articular surface of the metacarpal and may be of conical or some other shape that would aid retention and combat compression forces acting on the metacarpal. The trapezial component is larger than that of “a” above, and the underside of it may be flat to mate with a resected trapezium. Note that the amount of trapezial resection chosen may vary widely and none may be required based on individual patient anatomy.
[0127] In addition to being flat, the underside of the trapezial component may be of generic saddle shape or of a geometry that is patient specific and the top surface of the trapezial component may be shaped such that it is scalloped to better accommodate the native anatomy of the trapezium bone. The longitudinal edges of the trapezial component may be extended to provide both volar and dorsal capture elements which act to restrain excessive translation.
[0128] It may advantageous to utilise the embodiment of locating the ball on the trapezial component and by means of piloted counter boring, locate the centre of the ball distal to the resected end of the metacarpal. The effect of this countersunk placement may tighten the capsule ligaments and provide more stability to the joint. Note also that the metacarpal socket component may be shouldered such that a greater surface area is present to withstand migration of the device under compressive force.
[0129] c. “Semi-open Procedure”: In this configuration, the metacarpal component is threaded and is introduced in the manner of “a” above, while the trapezial component is introduced via a smaller incision than with “b” above. The trapezial component will be larger than that of “a” and may or may not be patient specific.
[0130] In circumstances whereby an elliptical aperture remains at the external surface of the metacarpal due to a metacarpal component insertion at an angle to the long axis of the metacarpal, the aperture may be filled with osteogenative material such as bone graft or some other orthobiologic agent. The same applies to screws with fenestration or truncated thread forms.
[0131] Post insertion, the patient may be cast or splinted for an adequate time to enable osteo-integration.
Application of the Invention
[0132] The device may be used in locations throughout the musculoskeletal system other than the carpometacarpal (CMC) joint, although the CMC joint is the area of focus in the device description below.
[0133] Other joints where the device in suitably modified form may be considered include:
[0134] Small joints of the hand: Interphalangeal, Metacarpophalangeal and Scaphotrapezial joints
[0135] Wrist: Radiocarpal and Distal radioulnar joint
[0136] Shoulder: Acromioclavicular joint
[0137] Ankle: Talotibial joint—central, medial and lateral surfaces.
[0138] Foot: Metatarsophalangeal, Tarsometatarsal, Naviculocuneiform and Interphalangeal joints
[0139] Elbow: Humeroulnar, Humeroradial and Superior radioulnar joints
[0140] Spine: Intravertebral or Sacroiliac and Facet joints
Advantages of One Preferred Embodiment
[0141] The trapezium bone does not need to be remodelled for the device to function. A surgeon may undertake some remodelling such as the removal of osteophytes, but this is not necessary for device function. [0142] There is no need to fix any device component in the trapezium. [0143] The base plate glides over the trapezium and is preferentially attached via the ball and socket to the stem, decreasing the risk of dislocation out of the trapezium as is seen in other hemiarthroplasty designs. [0144] The base plate is saddle shaped. It is convex-concave in keeping with the physiological shape of the trapezium bone. [0145] The base plate comes in several different radii of curvature, facilitating different bone morphologies [0146] When a ball and socket is employed, the implant is a true articulating hemiarthroplasty. The device does not need to reconfigure to function. [0147] During abduction-adduction, movement preferentially occurs at the ball and socket. This mimics the natural joint. [0148] During flexion-extension, movement preferentially occurs that the base plate and bone interface, again mimicking the natural joint. [0149] The ball and socket are within the metacarpal, mimicking the predominant point of rotation in the native joint. [0150] The movement of the implant at two points may allow forces to be distributed more evenly across the joint.
[0151] Although the implant of the invention has been specifically described with the complex biomechanics of the CMC joint in mind, the concept of an articulating hemiarthroplasty may be clinically useful in other joints with complex biomechanics, such as multiple motions occurring simultaneously, a shifting axis of rotation, or a combination of both. Examples include the distal radioulnar joint (DRUJ), elbow, shoulder, and first metatarsal joints.
EQUIVALENTS
[0152] The foregoing description details presently preferred embodiments of the present invention. Numerous modifications and variations in practice thereof are expected to occur to those skilled in the art upon consideration of these descriptions. Those modifications and variations are intended to be encompassed within the claims appended hereto.